Cost-effectiveness analysis of a state funded programme for control of severe asthma

Programa para o Controle da Asma e da Rinite Alérgica na Bahia (ProAR), Faculdade de Medicina, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil.
BMC Public Health (Impact Factor: 2.32). 02/2007; 7:82. DOI: 10.1186/1471-2458-7-82
Source: PubMed

ABSTRACT Asthma is one of the most common chronic diseases and a major economical burden to families and health systems. Whereas efficacy of current therapeutical options has been clearly established, cost-effectiveness analysis of public health interventions for asthma control are scarce.
81 patients with severe asthma (12-75 years) joining a programme in a reference clinic providing free asthma medication were asked retrospectively about costs and events in the previous 12 months. During 12 months after joining the programme, information on direct and indirect costs, asthma control by lung function, symptoms and quality of life were collected. The information obtained was used to estimate cost-effectiveness of the intervention as compared to usual public health asthma management. Sensitivity analysis was conducted.
64 patients concluded the study. During the 12-months follow-up within the programme, patients had 5 fewer days of hospitalization and 68 fewer visits to emergency/non scheduled medical visits per year, on average. Asthma control scores improved by 50% and quality of life by 74%. The annual saving in public resources was US$387 per patient. Family annual income increased US$512, and family costs were reduced by US$733.
A programme for control of severe asthma in a developing country can reduce morbidity, improve quality of life and save resources from the health system and patients families.


Available from: Laura C Rodrigues, Apr 21, 2015
  • Source
    Allergy 06/2008; 63(6). DOI:10.1111/j.1398-9995.2008.01730.x · 6.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A model for carbon and Ru corrosion in a DMFC anode under strong methanol depletion is developed. The model is based on current conservation equation in the membrane. In the methanol-depleted domain, methanol oxidation reaction is substituted by the carbon oxidation (corrosion). This dramatically lowers the membrane potential and creates an environment for electrochemical oxidation of Ru. Calculations show that 50–100mV loss in the cell potential manifests quite a significant (above 50%) methanol-depleted fraction of the cell active area.
    Electrochimica Acta 11/2011; 56(27):9846-9850. DOI:10.1016/j.electacta.2011.08.072 · 4.09 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate and compare full economic evaluation studies on the cost-effectiveness of enhanced asthma management (either as an adjunct to usual care or alone) vs. usual care alone. Online databases were searched for published journal articles in English language from year 1990 to 2012, using the search terms '"asthma" AND ("intervene" OR "manage") AND ("pharmacoeconomics" OR "economic evaluation" OR "cost effectiveness" OR "cost benefit" OR "cost utility")'. Hand search was done for local publishing. Only studies with full economic evaluation on enhanced management were included (cost consequences (CC), cost effectiveness (CE), cost benefit (CB), or cost utility (CU) analysis). Data were extracted and assessed for the quality of its economic evaluation design and evidence sources. A total of 49 studies were included. There were 3 types of intervention for enhanced asthma management: education, environmental control, and self-management. The most cost-effective enhanced management was a mixture of education and self-management by an integrated team of healthcare and allied healthcare professionals. In general, the studies had a fair quality of economic evaluation with a mean QHES score of 73.7 (SD=9.7), and had good quality of evidence sources. Despite the overall fair quality of economic evaluations but good quality of evidence sources for all data components, this review showed that the delivered enhanced asthma managements, whether as single or mixed modes, were overall effective and cost-reducing. Whilst the availability and accessibility are an equally important factor to consider, the sustainability of the cost-effective management has to be further investigated using a longer time horizon especially for chronic diseases such as asthma.
    Value in Health 10/2014; 12(4):493. DOI:10.1016/j.jval.2013.08.312 · 2.89 Impact Factor